Cara Therapeutics
CARA
#10367
Rank
C$11.2 M
Marketcap
C$7.35
Share price
-2.56%
Change (1 day)
1,841.35%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -C$85.64 Million

According to Cara Therapeutics 's latest financial reports the company's current earnings are C$7.13 Million. , an increase over its 2023 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -C$86.75 Million-45.49%
2023 -C$0.16 Billion31.6%
2022 -C$0.13 Billion-1.74%
2021 -C$0.13 Billion-1754.28%
2020 C$7.43 M-104.82%
2019 -C$0.16 Billion44.32%
2018 -C$0.11 Billion30.09%
2017 -C$82.18 Million1.86%
2016 -C$80.68 Million131.86%
2015 -C$34.8 Million39.38%
2014 -C$24.97 Million9120.41%
2013 -C$0.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Trevena
TRVN
-C$42.91 Million-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-C$0.11 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
C$5.19 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-C$14.22 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.37 B-18,975.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B-51,692.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-C$0.38 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA